Published in Am J Med Genet on June 30, 1998
Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol (2005) 2.62
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res A Clin Mol Teratol (2009) 1.29
Contemporary issues surrounding folic Acid fortification initiatives. Prev Nutr Food Sci (2014) 1.05
Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PLoS One (2012) 1.01
Cancer prevention and diet: help from single nucleotide polymorphisms. Proc Natl Acad Sci U S A (1999) 0.89
Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol (2004) 0.88
Analysis of MTHFR and MTRR Gene Polymorphisms in Iranian Ventricular Septal Defect Subjects. Int J Mol Sci (2013) 0.84
Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. Birth Defects Res A Clin Mol Teratol (2010) 0.83
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem (1999) 4.94
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM (1996) 3.31
Translocation as a species conservation tool: status and strategy. Science (1989) 3.31
Neurotoxic lesions of basolateral, but not central, amygdala interfere with Pavlovian second-order conditioning and reinforcer devaluation effects. J Neurosci (1996) 3.21
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today (1994) 3.13
The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med (1993) 3.09
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet (1992) 2.63
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40
Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol (1994) 2.31
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes (1979) 2.08
Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut (2003) 2.06
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians. Clin Pharmacol Ther (2007) 2.01
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Assignment of the structural gene for the third component of human complement to chromosome 19. Proc Natl Acad Sci U S A (1982) 2.00
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans. Clin Pharmacol Ther (2008) 1.90
Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87
Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J (1998) 1.83
Malformations in infants of diabetic mothers. Teratology (1982) 1.83
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem (1985) 1.79
Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans. Pharmacogenomics J (2007) 1.78
Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA (1994) 1.76
Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study. Am J Obstet Gynecol (1991) 1.75
Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med (1980) 1.73
Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73
Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis (1993) 1.63
Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63
Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62
The usefulness of lateral neck roentgenograms in laryngotracheobronchitis. Am J Dis Child (1979) 1.62
Should coitus late in pregnancy be discouraged? Lancet (1981) 1.62
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59
Maternal alcohol consumption and birth weight. How much drinking during pregnancy is safe? JAMA (1984) 1.58
Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr (1998) 1.56
Protecting the embryo from X-rated drugs. N Engl J Med (1995) 1.55
Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55
The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis (2001) 1.53
Are there adverse effects of periconceptional spermicide use? Fertil Steril (1985) 1.53
The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol (1997) 1.52
Localisation of the vaso-motor centre. J Physiol (1923) 1.51
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer. J Clin Oncol (2001) 1.50
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J (2001) 1.49
Vitamins, folic acid and neural tube defects: comments on investigations in the United States. Prenat Diagn (1991) 1.48
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology (2000) 1.47
Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1. J Biol Chem (1985) 1.47
Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest (1985) 1.45